Benign Prostatic Hyperplasia
Updated Treatment and Prevention Management
DOI:
https://doi.org/10.53366/jimki.v8i3.230Keywords:
Benign prostatic hyperplasia, management, prevention, treatmentAbstract
Background: Benign prostatic hyperplasia (BPH) is a histologic diagnosis which referred to a proliferation of ephitelial and smooth muscle tissues in the transitional zone of the prostate. BPH affects roughly 18-25% of all male aged 40 years and above and 90% of all male aged beyond 80. BPH is known to be able to significantly decrease quality of life and hence people with BPH need treatments to help them alleviate its effects.
Methods: The research was conducted using literature review from the most actual and respected clinical guidelines, scientific literatures, websites, and textbooks on BPH.
Discussion: There are three main groups of treatment, which are conservative, pharmacological, and surgical treatments. Treatment should be chosen from the least invasive first with the aim of increasing quality of life. Even if it is hard to prevent, several preventive measures could be conducted, such as limiting usage of BPH-inducing drugs, doing healthy lifestyle which involves no smoking, active exercise, body weight control, and balanced diet.
Conclusion: BPH is a very prevalent condition on elderly male population. Even though it is not deadly, a proper treatment management need to be done by virtue of its ability to significantly decrease quality of life.
References
1. McVary K, Roehrborn C. Management of benign prostatic hyperplasia [Internet]. American Urological Associaton. 2014 [cited 2020 Aug 28]. Available from: https://www.auanet.org/benign-prostatic-hyperplasia
2. Egan KB. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates. Urol Clin North Am. 2016 Aug;43(3):289–97.
3. Scher H, Eastham J. Benign and malignant diseases of the prostate. In: Harrison’s principles of internal medicine. 20th ed. New York: McGraw Hill Education; 2018. p. 623–32.
4. Mochtar C, Umbas R, Soebadi D, Rasyid N, Noegroho B, Poernomo BB, et al. Panduan penatalaksanaan klinis pembesaran prostat jinak (benign prostatyic hyperplasia/BPH). 2nd ed. Jakarta: Ikatan Ahli Urologi Indonesia; 2015. 12–25 p.
5. Stelzner S. Intraoperative management of iris prolapse [Internet]. American academy of ophthalmology. 2019 [cited 2020 Aug 30]. Available from: http://eyewiki.aao.org/Intraoperative_Management_of_Iris_Prolapse
6. Lue T. Male sexual dysfunction. In: Smith & Tanagho’s general urology. 18th ed. New York: McGraw Hill Education; 2013. p. 600, 610.
7. Pattanaik S, Mavuduru R, Panda A, Matthew J, Agarwal M, Hwang E, et al. Phosphodiesterase inhibitors for lower urinary tract symptims consistent with benign prostatic hyperplasia. Urol Clin North Am. 2018 Nov 16;(11).
8. National Cancer Institute. TURP [Internet]. National Cancer Institute. 2011 [cited 2020 Sep 1]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms
9. Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, et al. Dietary Patterns, Supplement Use, and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial. Am J Epidemiol. 2008 Apr 15;167(8):925–34.
10. Roehrborn C. Benign prostatic hyperplasia: etiology, pathophysiology, epidemiology, and natural history. In: Campbell-Walsh urology. 11th ed. Philadelphia: Elsevier; 2016. p. 2440–4.
2. Egan KB. The Epidemiology of Benign Prostatic Hyperplasia Associated with Lower Urinary Tract Symptoms: Prevalence and Incident Rates. Urol Clin North Am. 2016 Aug;43(3):289–97.
3. Scher H, Eastham J. Benign and malignant diseases of the prostate. In: Harrison’s principles of internal medicine. 20th ed. New York: McGraw Hill Education; 2018. p. 623–32.
4. Mochtar C, Umbas R, Soebadi D, Rasyid N, Noegroho B, Poernomo BB, et al. Panduan penatalaksanaan klinis pembesaran prostat jinak (benign prostatyic hyperplasia/BPH). 2nd ed. Jakarta: Ikatan Ahli Urologi Indonesia; 2015. 12–25 p.
5. Stelzner S. Intraoperative management of iris prolapse [Internet]. American academy of ophthalmology. 2019 [cited 2020 Aug 30]. Available from: http://eyewiki.aao.org/Intraoperative_Management_of_Iris_Prolapse
6. Lue T. Male sexual dysfunction. In: Smith & Tanagho’s general urology. 18th ed. New York: McGraw Hill Education; 2013. p. 600, 610.
7. Pattanaik S, Mavuduru R, Panda A, Matthew J, Agarwal M, Hwang E, et al. Phosphodiesterase inhibitors for lower urinary tract symptims consistent with benign prostatic hyperplasia. Urol Clin North Am. 2018 Nov 16;(11).
8. National Cancer Institute. TURP [Internet]. National Cancer Institute. 2011 [cited 2020 Sep 1]. Available from: https://www.cancer.gov/publications/dictionaries/cancer-terms
9. Kristal AR, Arnold KB, Schenk JM, Neuhouser ML, Goodman P, Penson DF, et al. Dietary Patterns, Supplement Use, and the Risk of Symptomatic Benign Prostatic Hyperplasia: Results from the Prostate Cancer Prevention Trial. Am J Epidemiol. 2008 Apr 15;167(8):925–34.
10. Roehrborn C. Benign prostatic hyperplasia: etiology, pathophysiology, epidemiology, and natural history. In: Campbell-Walsh urology. 11th ed. Philadelphia: Elsevier; 2016. p. 2440–4.
Downloads
Published
2021-02-21
Issue
Section
Article Review
How to Cite
Benign Prostatic Hyperplasia: Updated Treatment and Prevention Management. (2021). JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia, 8(3), 90-97. https://doi.org/10.53366/jimki.v8i3.230
Similar Articles
- Chairunna Amalia, Des Suryani, COMPARISON OF THE EFFECT OF BLACK CUMIN ( NIGELLA SATIVA) AND TEMULAWAK (CURCUMA XANTHORRHIZA) EXTRACT IN HISTOPATHOLOGY OF RATS HEPAR INDUCED BY PARACETAMOL , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 8 No. 3 (2021): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 8.3 Edisi September 2020 - Februari 2021
- Alfi Rahmatika, Muhammad Mufaiduddin, Innelya Innelya, The Potency of CtpF in Mycobacterium tuberculosis in The Development of CtpF-Inhibitors as Innovative Target Therapy in MDR/DR TB Treatment , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 10 No. 1 (2022): JIMKI (Jurnal Ilmiah Mahasiswa Kedokteran Indonesia) Volume 10 Nomor 1 Periode Maret-September 2022
- Arindi Maretzka, Bella Stevanny, Potensi Biji Pepaya (Carica papaya) Berbasis Pendekatan Terhadap BITC dan Karpain sebagai Alternatif Obat Anthelmintik pada Anak di Indonesia , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 6 No. 2 (2018): JIMKI : Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 6.2 Edisi Oktober - Desember 2018
- Muhammad Thifan Satyagraha, Andhwika Afif Fahrezi, Rafi Annisa Ulum, Gibran Chandra Syarif Hidayatullah, HUMAN EMBRYONIC STEM CELL DERIVATIVE SUBRETINAL PIGMENT EPITHELIAL TRANSPLANTATION AS A TREATMENT FOR DRY-TYPE MACULAR , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 9 No. 3 (2022): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 9.3 Edisi Desember 2021-April 2022
- Ahmad Razi Maulana Alnaz, Abdul Hakim Nasution, Aqyl Hanif Abdillah, Matrix Metalloproteinase (MMP) as Biomarker of Perforation in Acute Appencitis , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 8 No. 2 (2020): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 8.2 Edisi Maret - Agustus 2020
- Fachreza Aryo Damara, The Difference of Cadre Knowledge Before and After Handwashing Tele-Education in COVID-19 Outbreak at Burangrang Village, Bandung , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 8 No. 2 (2020): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 8.2 Edisi Maret - Agustus 2020
- Elina Rahma, Dwi Indria Anggraini, Use of Oral Fumaric Acid Esters in Treatment of Dermatology Cases , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 8 No. 2 (2020): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 8.2 Edisi Maret - Agustus 2020
- Surya Wijaya, Muthmainnah Arifin, Analisis Potensi Curcumin Kunyit (Curcuma longa) Sebagai Agen Neuroproktektor, Antiinflamasi, dan Antioksidan , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 1 No. 2 (2012): JIMKI : Jurnal Ilmiah Mahasiswa Kedokteran Indonesia
- Angiesta Pinakesty, CORRELATION BETWEEN CLUSTER OF DIFFERENTIATION 4 (CD4) WITH RADIOLOGICAL FEATURES OF TB-HIV PATIENS , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 9 No. 3 (2022): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 9.3 Edisi Desember 2021-April 2022
- Atikah Landani, Rani Himayani, Lacrimal System Disorders in Children , JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia: Vol. 8 No. 2 (2020): JIMKI: Jurnal Ilmiah Mahasiswa Kedokteran Indonesia Volume 8.2 Edisi Maret - Agustus 2020
You may also start an advanced similarity search for this article.